Johannes Stockl

Title: Innovations of Johannes Stockl

Introduction

Johannes Stockl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of rhinovirus infections. With a total of two patents to his name, Stockl's work is recognized for its innovative approach to addressing viral infections.

Latest Patents

Stockl's latest patents focus on a pharmaceutical composition designed for the prevention or treatment of human rhinovirus (HRV) infections. The composition includes an aldohexose, where the hydroxyl group at carbon 2 is substituted with various elements such as H, F, Cl, Br, I, SH, Me, OMe, and SMe, specifically highlighting 2-deoxy-glucose. Additionally, he has developed dispensers for intranasal administration, including nasal sprays and nose drop applicators that contain this pharmaceutical composition. Furthermore, his patents also encompass inhalation devices, such as metered-dose inhalers, dry-powder inhalers, and nebulizers that utilize the same composition.

Career Highlights

Johannes Stockl is affiliated with the Medical University of Vienna, where he conducts his research and development work. His innovative contributions have positioned him as a key figure in the pharmaceutical industry, particularly in the realm of viral infection treatment.

Collaborations

One of his notable collaborators is Guido Gualdoni, with whom he has worked closely on various projects related to his patents.

Conclusion

Johannes Stockl's work exemplifies the intersection of innovation and healthcare, particularly in combating viral infections. His patents reflect a commitment to advancing medical science and improving patient outcomes.